Cargando…
Targeting LncRNA-MALAT1 suppresses the progression of osteosarcoma by altering the expression and localization of β-catenin
Osteosarcoma (OS), which affects adolescents especially during a growth spurt, has the highest incidence of any primary malignant bone tumour, and a high rate of early metastasis leading to a very poor prognosis. In recent years, non-coding RNAs, especially long non-coding RNAs (lncRNAs) have attrac...
Autores principales: | Zhang, Zhi-Chang, Tang, Chun, Dong, Yang, Zhang, Jing, Yuan, Ting, Li, Xiao-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743713/ https://www.ncbi.nlm.nih.gov/pubmed/29290771 http://dx.doi.org/10.7150/jca.22113 |
Ejemplares similares
-
Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
por: Shi, Chuan-jian, et al.
Publicado: (2021) -
METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis
por: Li, Changshu, et al.
Publicado: (2023) -
LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway
por: Song, Xue-zhen, et al.
Publicado: (2020) -
TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway
por: Zhao, Xing, et al.
Publicado: (2021) -
LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging
por: Zhang, Jun, et al.
Publicado: (2020)